These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25787323)

  • 1. Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy.
    Aravind A; Yoshida Y; Maekawa T; Kumar DS
    Drug Deliv Transl Res; 2012 Dec; 2(6):418-36. PubMed ID: 25787323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA Aptamer-functionalized Polymeric Nanoparticles in Targeted Delivery and Cancer Therapy: An up-to-date Review.
    Marangoni K; Menezes R
    Curr Pharm Des; 2022; 28(34):2785-2794. PubMed ID: 36056830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X; Zhao Q; Qiu L
    J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment.
    Benedetto G; Vestal CG; Richardson C
    Target Oncol; 2015 Dec; 10(4):467-85. PubMed ID: 25989948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of aptamers in cancer research: an up-to-date review.
    Hu M; Zhang K
    Future Oncol; 2013 Mar; 9(3):369-76. PubMed ID: 23469972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyvalent mesoporous silica nanoparticle-aptamer bioconjugates target breast cancer cells.
    Li LL; Yin Q; Cheng J; Lu Y
    Adv Healthc Mater; 2012 Sep; 1(5):567-72. PubMed ID: 23184791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
    Dhar S; Gu FX; Langer R; Farokhzad OC; Lippard SJ
    Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17356-61. PubMed ID: 18978032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
    Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
    J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer-modified nanoparticles and their use in cancer diagnostics and treatment.
    Reinemann C; Strehlitz B
    Swiss Med Wkly; 2014 Jan; 144():w13908. PubMed ID: 24395443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in aptamer-mediated targeted delivery system for cancer treatment.
    He S; Du Y; Tao H; Duan H
    Int J Biol Macromol; 2023 May; 238():124173. PubMed ID: 36965552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamer applications for targeted cancer therapy.
    Barbas AS; Mi J; Clary BM; White RR
    Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric nanoparticle-aptamer bioconjugates can diminish the toxicity of mercury in vivo.
    Hu X; Tulsieram KL; Zhou Q; Mu L; Wen J
    Toxicol Lett; 2012 Jan; 208(1):69-74. PubMed ID: 22023738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
    Delač M; Motaln H; Ulrich H; Lah TT
    Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer-conjugated gold nanoparticles for bioanalysis.
    Zhang J; Liu B; Liu H; Zhang X; Tan W
    Nanomedicine (Lond); 2013 Jun; 8(6):983-93. PubMed ID: 23730697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamer-Mediated Targeted Delivery of Therapeutics: An Update.
    Catuogno S; Esposito CL; de Franciscis V
    Pharmaceuticals (Basel); 2016 Nov; 9(4):. PubMed ID: 27827876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer-Targeted Plasmonic Photothermal Therapy of Cancer.
    Kolovskaya OS; Zamay TN; Belyanina IV; Karlova E; Garanzha I; Aleksandrovsky AS; Kirichenko A; Dubynina AV; Sokolov AE; Zamay GS; Glazyrin YE; Zamay S; Ivanchenko T; Chanchikova N; Tokarev N; Shepelevich N; Ozerskaya A; Badrin E; Belugin K; Belkin S; Zabluda V; Gargaun A; Berezovski MV; Kichkailo AS
    Mol Ther Nucleic Acids; 2017 Dec; 9():12-21. PubMed ID: 29246290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery.
    Sayari E; Dinarvand M; Amini M; Azhdarzadeh M; Mollarazi E; Ghasemi Z; Atyabi F
    Int J Pharm; 2014 Oct; 473(1-2):304-15. PubMed ID: 24905777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology and aptamers: applications in drug delivery.
    Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
    Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
    Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
    J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.